Core Viewpoint - Aldeyra Therapeutics, Inc. is under investigation for potential violations of federal securities laws following the failure of its Phase III clinical trial for reproxalap, which was intended to treat dry eye disease [1][4]. Group 1: Company Overview - Aldeyra Therapeutics is a biotechnology company focused on developing therapies for immune-mediated and metabolic diseases, with reproxalap as its lead drug candidate for dry eye disease [2]. Group 2: Clinical Trial Results - The company announced the success of its Phase III dry eye chamber clinical trial, claiming the results were "uniquely supportive" and met FDA requirements for New Drug Application resubmission [3]. - However, the trial ultimately failed to demonstrate the efficacy of reproxalap in treating ocular symptoms associated with dry eyes, with methodological issues identified in the data [4]. Group 3: Stock Market Reaction - Following the FDA's Complete Response Letter on April 3, 2025, which stated that the NDA for reproxalap did not demonstrate efficacy, Aldeyra's stock price plummeted nearly 75%, dropping from $5.33 per share on April 2, 2025 [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Napco Security Technologies, Inc. regarding a class action lawsuit due to alleged misleading statements about the company's growth and hardware sales performance [1]. Summary by Sections Allegations - The complaint alleges that Napco's management provided investors with optimistic projections about the company's growth and strength in its hardware division, claiming confidence in achieving fiscal 2026 growth targets based on expected demand for hardware products [1]. - On February 3, 2025, Napco reported a significant decline in hardware sales, attributing this to reduced sales from two major distributors, which led to a retraction of their long-term EBITDA margin target of 45% [1]. - Following the announcement, Napco's stock price plummeted from $36.70 per share on January 31, 2024, to $26.93 per share on February 3, 2025, marking a decline of approximately 26.62% in one day [1]. Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by June 24, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle, with no cost or obligation to participate [2]. About the Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Napco Security Technologies, Inc. about a potential class action lawsuit due to significant declines in the company's stock price following disappointing financial results and revised growth projections [1][3]. Summary by Sections Class Action Notice - Shareholders who purchased shares of Napco Security Technologies (NASDAQ: NSSC) during the specified class period (February 5, 2024, to February 3, 2025) are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1][3]. Allegations - The complaint alleges that the defendants provided misleading information regarding Napco's expected growth and strength in its hardware division. They expressed confidence in achieving fiscal 2026 growth projections based on demand for hardware products [3]. - On February 3, 2025, Napco reported a significant decline in hardware sales, primarily due to reduced sales from two major distributors. Consequently, the company retracted its long-term 45% EBITDA margin target, stating uncertainty about achieving it by the end of fiscal 2026 [3]. - Following this announcement, Napco's stock price plummeted from $36.70 per share on January 31, 2024, to $26.93 per share on February 3, 2025, marking a decline of approximately 26.62% in one day [3]. Next Steps for Shareholders - Shareholders are advised to register for the class action by June 24, 2025, to participate in the case without any cost or obligation. Registered shareholders will receive updates through a portfolio monitoring software [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices. The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - The Schall Law Firm is investigating Backblaze, Inc. for potential violations of securities laws following a significant drop in its stock price due to a negative report from Morpheus Research [1][2]. Group 1: Investigation Details - The investigation centers on whether Backblaze made false or misleading statements and failed to disclose important information to investors [2]. - The company's stock experienced a sharp decline attributed to a critical report from Morpheus Research, which highlighted alleged financial missteps and questionable practices since its IPO in November 2021 [2]. Group 2: Allegations from the Report - The Morpheus Research report claims that Backblaze engaged in questionable accounting practices, including financial manipulations and inflated forecasts to meet audit thresholds [2].

NEW YORK, April 28, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of enCore Energy Corp. (NASDAQ: EU).Shareholders who purchased shares of EU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/encore-energy-corp-loss-submission-form/?id=145051&from=4CLASS PERIOD: March 28, 2024 to ...

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations by HarborOne Bancorp, Inc. related to its proposed acquisition by Eastern Bankshares, Inc. [1] Summary by Relevant Sections Acquisition Details - HarborOne Bancorp, Inc. is set to be acquired by Eastern Bankshares, Inc. Stockholders will receive either $12.00 in cash or 0.765 shares of Eastern Bankshares common stock for each share of HarborOne Bancorp they hold [1] - The total value of the transaction is approximately $490 million, with an expected closing date in the fourth quarter of 2025 [1] Legal Investigation - Rowley Law PLLC is conducting an investigation into the acquisition process to determine if there have been any violations of securities laws by HarborOne Bancorp and its board of directors [1]

Core Viewpoint - The Schall Law Firm is investigating Aldeyra Therapeutics, Inc. for potential violations of securities laws following a significant drop in share price after the FDA issued a Complete Response Letter regarding the company's drug reproxalap [1][2]. Group 1: Investigation Details - The investigation centers on whether Aldeyra made false or misleading statements or failed to disclose critical information to investors [2]. - On April 3, 2025, Aldeyra announced that the FDA's Complete Response Letter indicated that the NDA for reproxalap "failed to demonstrate efficacy in adequate and well controlled studies in treating ocular symptoms associated with dry eyes" [2]. - Despite Aldeyra's claims of "uniquely supportive" clinical trial data, the FDA expressed concerns regarding the trial data submitted as part of the NDA [2]. Group 2: Market Impact - Following the FDA's announcement, Aldeyra's shares plummeted by nearly 75% during trading on the same day [2].

BOSTON, April 21, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating TechTarget, Inc. (Nasdaq: TTGT) for potential securities law violations. Investors who have lost money in their TechTarget investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/ttgt. What is this all about? TechTarget announced a delay in filing its 2024 Annual Report and disclosed plans to record a significant goodwill impairment. This foll ...

Core Viewpoint - The Schall Law Firm is investigating OSI Systems, Inc. for potential violations of securities laws, particularly concerning misleading statements and undisclosed information related to the company's operations and financial performance [1][2]. Group 1: Investigation Details - The investigation centers on whether OSI Systems issued false or misleading statements and failed to disclose critical information to investors [2]. - A report by Culper Research claims that OSI Systems' reported revenue growth in Mexico is "largely an illusion" and suggests that the company has minimized the significance of a Department of Justice (DOJ) investigation through vague disclosures [2]. Group 2: Legal Representation - The Schall Law Firm offers free consultations for shareholders who believe they have suffered losses due to the alleged misconduct of OSI Systems [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].

Core Viewpoint - The Schall Law Firm is investigating Adverum Biotechnologies, Inc. for potential violations of securities laws related to misleading financial statements and disclosures [1][2]. Group 1: Investigation Details - The investigation centers on whether Adverum made false or misleading statements and failed to disclose critical information to investors [2]. - Adverum announced in an SEC filing on March 31, 2025, that certain previously issued financial statements should no longer be relied upon due to non-cash errors in accounting for tenant improvement allowances related to an operating lease in North Carolina [2]. - The company plans to restate its financial statements for the years ended December 31, 2022, and 2023, as well as unaudited quarterly financial information for 2023 and 2024 [2]. - Following this announcement, Adverum's shares dropped by over 12% on April 1, 2025 [2]. Group 2: Shareholder Rights - The Schall Law Firm encourages shareholders who suffered losses to participate in the investigation and offers free consultations regarding their rights [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].